Skip to content
SSAHelper.org

Social Security disability for bone marrow transplant: Blue Book listing 107.17

Listing 107.17 is the SSA Blue Book criteria SSA uses for bone marrow transplant childhood disability claims. Meeting it at step 3 of the disability evaluation approves the claim without further analysis of past work or other jobs in the national economy. This page covers what SSA looks for, the medical evidence the criteria require, and what happens if your records don't quite match.

Listing code

107.17

Children (Part B)

Body system

107.00

Hematological disorders (children)

Subsections

0

No lettered criteria

Step in evaluation

3 of 5

Listing match approves the claim

SSA listing text and criteria

Hematological disorders treated by bone marrow or stem cell transplantation (see 107.00F ). Consider under a disability for at least 12 consecutive months from the date of transplantation. After that, evaluate any residual impairment(s) under the criteria for the affected body system. Back to Top Support Contact us Find an office Forms Publications Report fraud Languages Espa&ntilde;ol Other languages Plain language Services for Employers & businesses Government agencies Other groups Representatives About Careers Chief actuary data Communications Financial reports Initiatives Research & policy Social Security Administration SSA.gov An official website of the Social Security Administration <ul class="columns" role="list" aria-labe

This listing has no lettered subsections. The diagnosis itself, supported by the medical evidence described in the body-system overview, is what SSA evaluates.

Source: SSA Blue Book listing 107.17. Last synced 2026-05-04.

Where claims under 107.17 usually fail

Missing the transplant link is a common problem, such as having a hematological diagnosis but not having documentation that it was treated with bone marrow or stem cell transplantation. Another frequent issue is using medical notes without the needed hematological-disorder proof, because SSA looks for a definitive laboratory test establishing the disorder (with the right physician involvement) or a persuasive physician report that confirms the diagnosis with appropriate laboratory analysis or other diagnostic methods. Some people also stop after proving the diagnosis and overlook the rule that, after at least 12 consecutive months from the transplant date, residual impairments must be evaluated under the criteria for the affected body system.

Medical evidence that strengthens this claim

For the hematological disorder itself, SSA needs a laboratory report of a definitive test establishing the disorder, signed by a physician. If the lab report is not signed by a physician, SSA needs a physician report stating the disorder plus that lab report. If there is no lab report, SSA needs a persuasive physician report that explains how the diagnosis was confirmed, including the definitive test(s) used and the results, or how the diagnosis was established by other diagnostic method(s) consistent with prevailing clinical practice.

What happens if your records do not meet this listing

This listing is built around the transplant event and the minimum 12 consecutive months rule. If the transplant requirement or the medical evidence for the hematological disorder is not met, the claim will not be handled under this transplant-based listing; instead, the decision would move to whether the child meets criteria elsewhere based on the affected hematological condition and any residual impairment after the transplant period. If the listing is met, the next step after the 12 consecutive months is evaluating any residual impairments under the criteria for the affected body system.

Work activity and the SGA gate for this condition

For SSDI claims involving a child treated by bone marrow or stem cell transplantation for a hematological disorder, SSA considers the child disabled for at least 12 consecutive months from the date of the transplantation. After that minimum period, any residual impairments are evaluated under the criteria for the affected body system, rather than continuing the transplant-based presumption. The core medical tie-in stays centered on the hematological disorder being supported by the needed definitive testing and documentation requirements.

Listing 107.17 FAQ

Questions that come up repeatedly for hematological disorders treated by bone marrow or stem cell transplantation disability claims.